Renal Biomarkers Market -Growing at Faster Rates with notable CAGR and achieve at a high valuation | Beckman Coulter, Inc., (Danaher Corporation), Thermo Fisher Scientific Inc.

Chronic kidney disease (CKD) involves gradual loss of functioning of kidneys. The normal function of kidneys are to filter out and excrete wastes, and excess fluids from the blood are excreted through urine. However, when an individual is suffering from chronic kidney disease, kidneys cannot perform their natural function and wastes, fluids, and electrolytes build up in the body in excess amounts. Signs and symptoms of chronic kidney disease are not apparent until kidney function becomes significantly impaired. For this purpose various diagnostic tests are performed which involve use of various tests which asses biomarkers to understand functioning of the kidneys. Increase or decrease in values of these biomarkers indicates dysfunction of kidneys.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/3551

Global Renal Biomarkers Market: Drivers

Increasing prevalence of chronic kidney diseases is expected to propel growth of the global renal biomarkers market over the forecast period. For instance, according to European Renal Association – European Dialysis and Transplant Association’s data in 2018, over 850 million people worldwide have some form of kidney disease.

Moreover, increasing rate of progression of chronic kidney disease in children is also expected to aid in growth of the market. For instance, according to the study, ‘Risk Factors and Rate of Progression of CKD in Children’, published in June 2019 in Kidney International Reports, 38% children experienced progression of chronic kidney disease within 2 years of follow-up.

North America region held dominant position in the global renal biomarkers market in 2018, accounting for 32.5% share in terms of value, followed by Europe.

Global Renal Biomarkers Market: Restraints

Low sensitivity and specificity of biomarkers is expected to hinder growth of the global renal biomarkers market. For instance, some renal biomarkers such as L-18 are more specific although are not very sensitive, while other biomarkers such as osteopontin are highly sensitive though they are not specific.

Moreover, use of unreliable, imperfect gold standards is also expected to limit growth of the market. Serum creatinine, although having low sensitivity and specificity, is used as gold standard. Serum creatinine does not distinguish whether the reason for rise in levels is due to renal injury or other non-renal causes such as hemodynamic (obstructive uropathy) mediated changes. Moreover, serum creatinine is also not effective in renal recovery and injury.

Global Renal Biomarkers Market: Competitive Landscape

Major players operating in the global renal biomarkers market include, Beckman Coulter, Inc., (Danaher Corporation), Thermo Fisher Scientific Inc., Abbott Laboratories, BIOPORTO A/S, Astute Medical, Inc., Randox Laboratories Ltd., and SphingoTec GmbH.

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/3551

Global Renal Biomarkers Market: Key Developments

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in January 2020, SphingoTec GmbH launched IB10 sphingotest penKid, a CE-IVD-marked point-of-care test for Proenkephalin, a renal biomarker.

Players in the market are also focused on approval and launch of new biomarkers to expand their product portfolio. For instance, in November 2019, BioPorto A/S announced to supplement its pediatric 510(k) application to the U.S. FDA with additional data for regulatory clearance of The NGAL Test (a biomarker test) for pediatric risk assessment of acute kidney injury.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.